Metastatic Cancer

Showing NaN - NaN of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Tumor, Tumor, Solid, Metastasis Trial in United States (nab-sirolimus)

Recruiting
  • Tumor
  • +20 more
  • Mobile, Alabama
  • +81 more
Jan 24, 2023

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in Sarasota, Nashville (DS-9606a)

Recruiting
  • Advanced Cancer
  • +3 more
  • Denver, Colorado
  • +6 more
Jan 12, 2023

Advanced Cancer, Metastatic Cancer, Solid Tumor Trial in United States (JZP815)

Recruiting
  • Advanced Cancer
  • +2 more
  • Denver, Colorado
  • +4 more
Jan 10, 2023

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01876, Nivolumab, Ipilimumab)

Completed
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +37 more
Dec 6, 2022

Squamous Cell Carcinoma of Head and Neck, NSCLC, Hepatocellular Carcinoma Trial in Worldwide (KY1044, KY1044 and atezolizumab)

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +11 more
  • New Haven, Connecticut
  • +12 more
Nov 3, 2022

Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

Active, not recruiting
  • Neoplasms
  • +6 more
  • Scottsdale, Arizona
  • +7 more
Oct 31, 2022

Biliary Tract Cancer, Metastatic Cancer, Advanced Cancer Trial in Worldwide (Ramucirumab, Merestinib, Cisplatin)

Active, not recruiting
  • Biliary Tract Cancer
  • +2 more
  • Tucson, Arizona
  • +91 more
Oct 18, 2022

Advanced Solid Tumor, Advanced Malignant Tumor, Metastatic Cancer Trial in United States (PC14586)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Los Angeles, California
  • +10 more
Aug 12, 2022

Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer Trial in United States (CGT9486 plus sunitinib, CGT9486, Sunitinib)

Recruiting
  • Advanced Gastrointestinal Stromal Tumors
  • Metastatic Cancer
  • CGT9486 plus sunitinib
  • +2 more
  • Duarte, California
  • +11 more
Aug 10, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Advanced Malignancies, Metastatic Cancer Trial in United States (INCAGN01876)

Completed
  • Advanced Malignancies
  • Metastatic Cancer
  • Los Angeles, California
  • +7 more
Feb 9, 2021

Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity Trial in Canada, United States (management of therapy

Completed
  • Cognitive/Functional Effects
  • +2 more
  • management of therapy complications
  • quality-of-life assessment
  • Birmingham, Alabama
  • +240 more
Oct 21, 2020

Metastatic Cancer, Radiation Toxicity, Solid Tumor Trial in Canada, United States (therapeutic melatonin, radiation therapy)

Completed
  • Metastatic Cancer
  • +2 more
  • therapeutic melatonin
  • radiation therapy
  • Birmingham, Alabama
  • +233 more
Oct 21, 2020

Metastatic Cancer Trial in Nashville, San Antonio (ARRY-382, cFMS inhibitor; oral)

Completed
  • Metastatic Cancer
  • ARRY-382, cFMS inhibitor; oral
  • Nashville, Tennessee
  • +1 more
Sep 17, 2020

Locally Advanced Cancer, Metastatic Cancer Trial in United States (OMP-313M32, Nivolumab)

Terminated
  • Locally Advanced Cancer
  • Metastatic Cancer
  • Scottsdale, Arizona
  • +4 more
Aug 10, 2020

Advanced Malignancies, Metastatic Cancer Trial in Worldwide (INCAGN01949)

Completed
  • Advanced Malignancies
  • Metastatic Cancer
  • New Brunswick, New Jersey
  • +7 more
May 6, 2020

Metastatic Cancer, Prostate Cancer Trial in Canada, United States (drug, other, dietary supplement)

Completed
  • Metastatic Cancer
  • Prostate Cancer
  • zoledronic acid
  • +5 more
  • Mobile, Alabama
  • +240 more
Apr 28, 2020